NIPAL3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.766200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.830000E-01
Normal-vs-Stage2
7.373400E-01
Normal-vs-Stage3
2.406800E-01
Normal-vs-Stage4
3.202000E-01
Stage1-vs-Stage2
6.606800E-01
Stage1-vs-Stage3
1.535190E-01
Stage1-vs-Stage4
4.091800E-01
Stage2-vs-Stage3
1.445770E-01
Stage2-vs-Stage4
7.430400E-02
Stage3-vs-Stage4
1.085180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.886400E-01
Normal-vs-AfricanAmerican
4.930800E-01
Normal-vs-Asian
9.004600E-01
Caucasian-vs-AfricanAmerican
5.638400E-01
Caucasian-vs-Asian
8.181400E-01
AfricanAmerican-vs-Asian
5.543600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.582600E-01
Normal-vs-Female
6.937000E-01
Male-vs-Female
2.629000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.540800E-01
Normal-vs-Age(41-60Yrs)
5.413800E-01
Normal-vs-Age(61-80Yrs)
8.543600E-01
Normal-vs-Age(81-100Yrs)
9.674600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.526600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.421800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.826400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.955600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.351200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.998200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.147400E-01
Normal-vs-Daily Drinker
8.292200E-01
Normal-vs-Weekly Drinker
7.313800E-01
Normal-vs-Occasional Drinker
3.626000E-01
Normal-vs-Social Drinker
7.970400E-01
Non Drinker-vs-Daily Drinker
2.239400E-01
Non Drinker-vs-Weekly Drinker
9.901800E-01
Non Drinker-vs-Occasional Drinker
1.486200E-02
Non Drinker-vs-Social Drinker
2.428400E-01
Daily Drinker-vs-Weekly Drinker
3.234600E-01
Daily Drinker-vs-Occasional Drinker
8.614000E-02
Daily Drinker-vs-Social Drinker
9.225200E-01
Weekly Drinker-vs-Occasional Drinker
3.229600E-02
Weekly Drinker-vs-Social Drinker
3.307400E-01
Occasional Drinker-vs-Social Drinker
1.329420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.787700E-02
Normal-vs-Grade 2
9.558300E-03
Normal-vs-Grade 3
1.999090E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.037600E-01
Grade 1-vs-Grade 3
5.673800E-01
Grade 1-vs-Grade 4
7.787700E-02
Grade 2-vs-Grade 3
9.172600E-01
Grade 2-vs-Grade 4
9.558300E-03
Grade 3-vs-Grade 4
1.999090E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.887400E-01
Normal-vs-NonDiabetic
9.204600E-01
Diabetic-vs-NonDiabetic
5.385200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.121600E-01
Normal-vs-NoPancreatitis
8.917800E-01
Pancreatitis-vs-NoPancreatitis
2.370800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.488800E-01
Normal-vs-N1
7.843000E-01
N0-vs-N1
7.718400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.238600E-01
Normal-vs-TP53-NonMutant
6.151800E-01
TP53-Mutant-vs-TP53-NonMutant
4.648500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
